Aeolus Pharmaceuticals

0 followers


Aeolus Pharmaceuticals develops lead compound, AEOL-10150, as a treatment for the pulmonary and delayed effects of acute radiation exposure.

Industries

+1

Headquarters

Stage

Employees

Links